Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Browse by collection
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Browse by collection
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 99, Issue 2
Efficacy and adverse events of aflibercept, ranibizumab and bevacizumab in age-related macular degeneration: a trade-off analysis
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Review
Efficacy and adverse events of aflibercept, ranibizumab and bevacizumab in age-related macular degeneration: a trade-off analysis
Online download statistics by month:
Online download statistics by month: June 2014 to February 2024
Abstract
Full
Pdf
Jun 2014
474
12
111
Jul 2014
111
10
34
Aug 2014
43
0
7
Sep 2014
71
2
9
Oct 2014
187
160
162
Nov 2014
165
85
72
Dec 2014
114
66
71
Jan 2015
894
80
159
Feb 2015
1014
74
171
Mar 2015
413
63
74
Apr 2015
198
51
67
May 2015
184
55
55
Jun 2015
157
31
44
Jul 2015
115
24
25
Aug 2015
129
39
49
Sep 2015
91
27
33
Oct 2015
70
14
24
Nov 2015
108
35
48
Dec 2015
82
22
21
Jan 2016
106
40
45
Feb 2016
82
24
28
Mar 2016
68
32
29
Apr 2016
87
18
29
May 2016
62
13
11
Jun 2016
65
12
21
Jul 2016
60
11
15
Aug 2016
57
14
12
Sep 2016
81
10
14
Oct 2016
62
16
13
Nov 2016
43
22
17
Dec 2016
36
11
14
Jan 2017
102
21
21
Feb 2017
71
12
15
Mar 2017
54
25
21
Apr 2017
107
29
19
May 2017
260
33
21
Jun 2017
312
17
8
Jul 2017
228
22
21
Aug 2017
172
25
16
Sep 2017
319
22
14
Oct 2017
411
29
16
Nov 2017
201
23
8
Dec 2017
191
42
6
Jan 2018
175
43
9
Feb 2018
149
41
10
Mar 2018
161
50
13
Apr 2018
197
44
8
May 2018
220
30
15
Jun 2018
233
43
15
Jul 2018
176
48
9
Aug 2018
140
43
9
Sep 2018
130
38
5
Oct 2018
184
31
4
Nov 2018
143
31
9
Dec 2018
156
35
8
Jan 2019
141
28
2
Feb 2019
118
37
11
Mar 2019
115
5
7
Apr 2019
120
6
5
May 2019
85
20
7
Jun 2019
87
31
4
Jul 2019
101
29
6
Aug 2019
93
30
8
Sep 2019
83
23
1
Oct 2019
100
22
4
Nov 2019
111
26
6
Dec 2019
93
26
4
Jan 2020
62
26
2
Feb 2020
122
28
3
Mar 2020
102
35
6
Apr 2020
130
30
9
May 2020
122
40
7
Jun 2020
97
23
6
Jul 2020
95
21
3
Aug 2020
74
24
5
Sep 2020
85
20
0
Oct 2020
73
23
4
Nov 2020
63
17
6
Dec 2020
115
31
4
Jan 2021
63
6
7
Feb 2021
103
6
4
Mar 2021
84
3
4
Apr 2021
79
15
1
May 2021
41
5
5
Jun 2021
4
4
4
Jul 2021
12
12
8
Aug 2021
5
4
2
Sep 2021
10
9
4
Oct 2021
63
9
6
Nov 2021
186
10
2
Dec 2021
82
4
5
Jan 2022
150
12
12
Feb 2022
95
4
2
Mar 2022
114
6
1
Apr 2022
79
8
2
May 2022
148
11
4
Jun 2022
132
8
0
Jul 2022
152
11
3
Aug 2022
88
12
1
Sep 2022
146
13
7
Oct 2022
175
21
3
Nov 2022
109
6
1
Dec 2022
92
3
0
Jan 2023
138
6
4
Feb 2023
94
2
1
Mar 2023
29
1
1
Apr 2023
109
11
2
May 2023
79
5
3
Jun 2023
66
1
1
Jul 2023
63
3
5
Aug 2023
89
3
2
Sep 2023
125
6
1
Oct 2023
80
2
2
Nov 2023
120
4
2
Dec 2023
93
9
2
Jan 2024
98
3
3
Feb 2024
172
11
2
Total
15875
2720
2023
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?